Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

147429 Press Releases
DateTitleCompany
07 Mar 16 Ossur Hf : Candidates to the Board of Directors Ossur Hf,
Published by
GlobeNewswire
07 Mar 16 Probiodrug AG to Publish its Full Year 2015 Results on March 15, 2016 Probiodrug,
Published by
GlobeNewswire
07 Mar 16 NEOVACS REPORTS FULL YEAR 2015 FINANCIAL RESULTS NEOVACS,
Published by
GlobeNewswire
07 Mar 16 Galapagos selected for BEL 20 Index Galapagos NV,
Published by
GlobeNewswire
07 Mar 16 New Preclinical Data for Calcipotriol/betamethasone dipropionate (0,005%/0,05%) Foam Presented at American Academy of Dermatology Congress LEO Pharma A/S,
Published by
PR Newswire
07 Mar 16 PeptiDream Announces License of PDPS Technology to Lilly PeptiDream Inc.,
Published by
Business Wire
07 Mar 16 Melanoma Pipeline Market Research Report for H2 2015 ReportsnReports,
Published by
PR Newswire
07 Mar 16 Dr. Lee's Spine Center Highlights the Importance of Weight Management for Back Pain Published by
GlobeNewswire
07 Mar 16 MediciNova Announces Positive Findings From a Completed Phase 2 Trial of MN-166 (ibudilast) in Opioid Dependence at the Behavior, Biology and Chemistry: Translational Research in Addiction Meeting in San Antonio, Texas Published by
GlobeNewswire
07 Mar 16 DBV Technologies: Additional Phase IIb Trial Results with Viaskin Peanut Presented at the 2016 AAAAI Meeting Continue to Support Treatment Safety, Efficacy and Compliance Published by
GlobeNewswire
07 Mar 16 Aimmune Therapeutics Announces Phase 2 Follow-On Study of AR101 for the Treatment of Peanut Allergy Demonstrated Increased Desensitization and Improved Tolerability with Low-Dose Maintenance Aimmune Therapeutics, Inc.,
Published by
Business Wire
06 Mar 16 DBV Technologies: Additional Phase IIb Trial Results with Viaskin Peanut Presented at the 2016 AAAAI Meeting Continue to Support Treatment Safety, Efficacy and Compliance DBV Technologies,
Published by
PharmiWeb.com
06 Mar 16 Discuss new oncology drugs for children at Paediatric Clinical Trials this March SMi Group Ltd
06 Mar 16 Reed Chiropractic Clinic Raising Awareness About Spinal Decompression Therapy Published by
GlobeNewswire
06 Mar 16 Maple Ridge Eye Care Announces New Addition to Clinic, Optometrist Dr. Priya Rughani Published by
GlobeNewswire
06 Mar 16 Chiropractic Health Clinic Warns Area Residents About Injury Related to Winter Activities, Offers Chiropractic Remedy Published by
GlobeNewswire
06 Mar 16 Back to Health Center Addresses Prevention and Chiropractic Treatment of Gardening Injuries Published by
GlobeNewswire
06 Mar 16 Hobson Eye Associates Offers Daily Disposable Contact Lenses to Combat Surge of Acanthamoeba Published by
GlobeNewswire
06 Mar 16 Lubbock Advanced Physical Medicine Offers Unique Stem Cell Therapy Treatment Published by
GlobeNewswire
05 Mar 16 Novartis' Cosentyx superior to Stelara in delivering long-lasting skin clearance (PASI 90) for psoriasis patients at 52 weeks Novartis International AG,
Published by
GlobeNewswire
04 Mar 16 Cellectar Biosciences Announces 1-for-10 Reverse Stock Split Published by
GlobeNewswire
05 Mar 16 Immucor Acquires Sirona Genomics Published by
GlobeNewswire
04 Mar 16 Gilead Sciences to Present at the Cowen & Company 36th Annual Health Care Conference on Monday, March 7 Gilead Sciences, Inc.,
Published by
Business Wire
04 Mar 16 LeMaitre Vascular to Participate in the Cowen and Company 36th Annual Health Care Conference on March 9, 2016 Published by
GlobeNewswire
05 Mar 16 Gilead Sciences Announces Settlement Method for 1.625% Convertible Senior Notes Due 2016 Gilead Sciences, Inc.,
Published by
Business Wire
05 Mar 16 Bellerophon Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference Published by
GlobeNewswire
05 Mar 16 Revance Announces Late-Breaking Podium Presentation of Positive 6-Month Duration Results for BELMONT Phase 2 Active Comparator Study of Injectable RT002 at the 74th Annual Meeting of the American Academy of Dermatology Published by
GlobeNewswire
05 Mar 16 Douglas Crawford Leaves University Role in QB3 Ecosystem QB3,
Published by
PR Newswire
05 Mar 16 Chugai Announces Phase II Global Study Results of Nemolizumab (CIM331) in Late-breaking Research Forums at AAD Chugai Pharmaceutical Co., Ltd.,
Published by
Business Wire
05 Mar 16 Stallergenes Greer Presents Findings from Four Allergy Immunotherapy Studies at the 2016 AAAAI Annual Meeting Stallergenes Greer,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.